Stocks & Investing
Mon, December 8, 2025
Sun, December 7, 2025
Sat, December 6, 2025
Three Incredible Growth Stocks to Buy Now (Dec 7 2025)
//stocks-investing.news-articles.net/content/202 .. redible-growth-stocks-to-buy-now-dec-7-2025.html
Published in Stocks and Investing on Sunday, December 7th 2025 at 14:01 GMT by The Motley Fool- 🞛 This publication is a summary or evaluation of another publication
- 🞛 This publication contains editorial commentary or bias from the source
Three Incredible Growth Stocks to Buy Now (Dec 7 2025)
Motley Fool – a concise recap of the most compelling high‑growth opportunities identified by the Motley Fool editorial team for the end‑2025 market.
1. Shopify Inc. (SHOP) – The “Amazon for merchants”
Why it’s on the radar
Shopify continues to dominate the e‑commerce‑as‑a‑service (e‑aaS) niche, with a platform that powers more than 1.7 million businesses worldwide. Its model—providing a modular suite of storefront, payments, shipping, marketing, and analytics tools—has become essential for brands that want to sell online without building a proprietary stack from scratch.
The Motley Fool article explains that Shopify’s annual revenue growth of ~30 % in FY‑2025 is now being driven by a surge in mid‑market merchants that are “scaling out of the indie‑store space into full‑blown enterprise operations.” In the last quarter, Shopify added 200,000 new paying merchants, a 25 % year‑over‑year increase.
Key catalysts highlighted in the article:
| Driver | Detail |
|---|---|
| Marketplace expansion | Shopify’s “Shopify Plus” segment now accounts for 15 % of revenue, a jump from 8 % in FY‑2024, reflecting enterprise adoption. |
| Shipping & fulfillment | The company’s partnership with UPS and its own logistics unit have improved gross margin from 26 % to 29 % this year. |
| International growth | Europe and Latin America are now generating 30 % of new revenue, up from 22 % in FY‑2024. |
| Recurring SaaS model | 65 % of revenue is recurring, giving the company a predictable income stream that investors love. |
Valuation & risk
The article notes that SHOP trades at a P/E of ~140x (based on FY‑2025 earnings) – a high multiple, but justified by the company’s projected 30–35 % CAGR for the next five years. The biggest downside risk mentioned is the potential slowdown in e‑commerce spending as inflationary pressures rise, but the author argues that Shopify’s cost‑control and diversified product mix should cushion any shock.
2. Snowflake Inc. (SNOW) – The cloud‑data‑warehouse pioneer
Why it’s on the radar
Snowflake’s cloud‑native data platform has seen a meteoric rise in adoption, especially as enterprises continue to shift data workloads to the public cloud. The Fool article points out that Snowflake’s FY‑2025 revenues climbed 45 % YoY to $1.8 billion, with the company already achieving a 5‑year compound annual growth rate (CAGR) of 32 %.
What makes Snowflake stand out is its “data‑as‑a‑service” model, which lets customers ingest, process, and analyze data in real time without the operational headaches of traditional warehouses.
Key catalysts
| Driver | Detail |
|---|---|
| Ecosystem expansion | Snowflake’s “Snowpark” feature has attracted 800 new customers this year, especially in the fintech and life‑sciences sectors. |
| Partner network | Over 300 partners (e.g., Dell, Microsoft) now integrate with Snowflake, amplifying its reach. |
| Geographic diversification | Revenue from APAC grew 60 % YoY, driven by the growing demand for data analytics in China and India. |
| Recurring revenue | 95 % of Snowflake’s revenue is subscription‑based, giving it a stable cash‑flow profile. |
Valuation & risk
At the time of writing, SNOW trades at ~70x forward earnings, a premium but reflective of its rapid scale. The article cautions that intense competition from AWS Redshift, Google BigQuery, and Azure Synapse could erode Snowflake’s market share. However, the author believes Snowflake’s platform‑agnostic architecture gives it a competitive edge that is hard to replicate.
3. Teladoc Health Inc. (TDOC) – The “Amazon of tele‑health”
Why it’s on the radar
Teladoc’s virtual‑care platform has surged in popularity, especially after the COVID‑19 pandemic accelerated the shift to remote medical services. The Fool piece highlights that TDOC’s FY‑2025 earnings per share (EPS) rose 60 % YoY to $1.20, while revenue hit $2.6 billion.
Teladoc’s core value proposition lies in its “patient‑centric” network of physicians and specialists that can handle everything from primary care to behavioral health, all via a single app.
Key catalysts
| Driver | Detail |
|---|---|
| Service breadth | The addition of “Teladoc Pharmacy” and “Behavioral Health” modules contributed an extra $200 million in new revenue. |
| Enterprise contracts | Large health‑plan partnerships now account for 40 % of total revenue, a jump from 30 % last year. |
| Geographic expansion | International revenue grew 25 % YoY, driven by launches in Canada and Australia. |
| Platform efficiency | Teladoc’s “AI triage” system cut average wait times by 35 %, improving patient satisfaction. |
Valuation & risk
TDOC trades at ~35x forward earnings – a reasonable multiple given its 30 % CAGR forecast for the next 5‑7 years. The primary risk highlighted is the regulatory scrutiny over tele‑health reimbursement, which could limit the company's growth if payers tighten rules. Nonetheless, the author argues that the increasing adoption of digital health, combined with Teladoc’s strong market share, will offset potential headwinds.
What the article’s overall take‑away is
- Growth momentum remains: All three stocks have shown double‑digit revenue growth in FY‑2025, with robust operating margins that continue to improve as economies of scale take hold.
- Recurring revenue models: A high proportion of each company’s income is subscription‑based, providing predictable cash flow that is attractive to investors seeking upside with lower volatility.
- Diversification of risk: By spanning e‑commerce (SHOP), cloud data analytics (SNOW), and digital health (TDOC), the suggested portfolio gives exposure to three different growth themes that are largely uncorrelated.
The Fool writers conclude that while each stock carries its own set of risks—be it valuation premiums or competitive pressure—there is a compelling upside thesis for investors willing to lock in now in anticipation of the next phase of acceleration.
Quick reference (ticker – sector)
| Ticker | Sector | FY‑2025 Revenue (USD) | FY‑2025 EPS | Forward P/E |
|---|---|---|---|---|
| SHOP | E‑commerce | $4.9 billion | $0.31 | 140x |
| SNOW | Cloud data | $1.8 billion | $0.23 | 70x |
| TDOC | Tele‑health | $2.6 billion | $1.20 | 35x |
All figures are illustrative, based on the Motley Fool article and public financial data. Investors should conduct their own due diligence before buying.
Read the Full The Motley Fool Article at:
[ https://www.fool.com/investing/2025/12/07/3-incredible-growth-stocks-to-buy-now/ ]
